ATC Group: N01AH03 Sufentanil

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N01AH03 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N01 Anesthetics
3 N01A Anesthetics, general
4 N01AH Opioid anesthetics
5 N01AH03 Sufentanil

Active ingredients in N01AH03

Active Ingredient Description
Sufentanil

Sufentanil is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine. Structurally, sufentanil differs from fentanyl through the addition of a methoxymethyl group on the piperidine ring (which is believed to reduce duration of action), and the replacement of the phenyl ring by thiophene. The main use of this medication is in operating suites and critical care where pain relief is required for a short period of time. It also offers properties of sedation and this makes it a good analgesic component of anesthetic regimen during an operation

Related product monographs

Title Information Source Document Type  
DZUVEO Sublingual tablet European Medicines Agency (EU) MPI, EU: SmPC
SOFENTIL Solution for injection / infusion Web Search MPI, EU: SmPC
SUFENTA Solution for injection / infusion Health Products Regulatory Authority (ZA) MPI, Generic
ZALVISO Sublingual tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Croatia (HR)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Ireland (IE)

Lithuania (LT)

Malta (MT)

Poland (PL)

Romania (RO)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.